Corcept Therapeutics (NASDAQ:CORT) is a $368M (as of 4/14/2014) pharmaceutical company located in Menlo Park, CA, with 44 employees. Doctors Joseph Belanoff and Alan Schatzberg co-founded Corcept in 1998. Dr. Belanoff previously held multiple positions in the Department of Psychiatry and Behavioral Sciences at Stanford University and is now the CEO of Corcept. While at Stanford Dr. Belanoff published extensively on glucocorticoid signaling with Dr. Schatzberg. Dr. Schatzberg is a professor in the Stanford University School of Medicine Psychiatry and Behavioral Sciences Department and is an expert on glucocorticoid signaling. In the field of psychiatry he had held important administrative appointments, including President of the American Psychiatric Association, won numerous awards, and has published extensively.
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|